MENU
+Compare
IMMX
Stock ticker: NASDAQ
AS OF
Jun 27, 04:59 PM (EDT)
Price
$2.16
Change
-$0.08 (-3.57%)
Capitalization
60.08M

IMMX Immix Biopharma Forecast, Technical & Fundamental Analysis

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications... Show more

IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IMMX with price predictions
Jun 26, 2025

IMMX in +3.32% Uptrend, rising for three consecutive days on June 12, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IMMX advanced for three days, in of 155 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Aroon Indicator entered an Uptrend today. In of 82 cases where IMMX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IMMX moved out of overbought territory on June 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IMMX as a result. In of 67 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IMMX turned negative on June 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 32 similar instances when the indicator turned negative. In of the 32 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMMX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IMMX broke above its upper Bollinger Band on May 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMMX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.262) is normal, around the industry mean (16.566). P/E Ratio (0.000) is within average values for comparable stocks, (58.942). IMMX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.298). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (254.026).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMMX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IMMX is expected to report earnings to rise 40.00% to -20 cents per share on September 03

Immix Biopharma IMMX Stock Earnings Reports
Q2'25
Est.
$-0.21
Q1'25
Beat
by $0.08
Q4'24
Est.
$-0.25
Q3'24
Missed
by $0.08
Q2'24
Est.
$-0.15
The last earnings report on May 28 showed earnings per share of -15 cents, beating the estimate of -23 cents. With 170.81K shares outstanding, the current market capitalization sits at 60.08M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11400 West Olympic Boulevard
Phone
+1 310 651-8041
Employees
17
Web
https://www.immixbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OXM39.752.26
+6.03%
Oxford Industries
CTO17.310.01
+0.06%
CTO Realty Growth
AZN69.84-0.23
-0.33%
AstraZeneca PLC
MUR22.93-0.19
-0.82%
Murphy Oil Corp
IRD0.99-0.03
-2.56%
Opus Genetics Inc

IMMX and Stocks

Correlation & Price change

A.I.dvisor tells us that IMMX and IMTX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMX and IMTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
+1.13%
IMTX - IMMX
32%
Poorly correlated
+2.38%
COGT - IMMX
32%
Poorly correlated
+3.68%
XERS - IMMX
32%
Poorly correlated
+0.64%
RNAC - IMMX
30%
Poorly correlated
+6.51%
SYRE - IMMX
30%
Poorly correlated
+3.96%
More